Symbol="MORF"
AssetType="Common Stock"
Name="Morphic Holding Inc"
Description="Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small molecule integrin therapies for the treatment of autoimmune, cardiovascular, metabolic, fibrosis, and cancer diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1679363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="35 GATEHOUSE DRIVE A2, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2669782000"
EBITDA="-141562000"
PERatio="None"
PEGRatio="None"
BookValue="15.23"
DividendPerShare="0"
DividendYield="0"
EPS="-1.6"
RevenuePerShareTTM="0.218"
ProfitMargin="0"
OperatingMarginTTM="-16.37"
ReturnOnAssetsTTM="-0.153"
ReturnOnEquityTTM="-0.232"
RevenueTTM="8711000"
GrossProfitTTM="-31254000"
DilutedEPSTTM="-1.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.781"
AnalystTargetPrice="75.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="14.03"
PriceToBookRatio="2.901"
EVToRevenue="9.32"
EVToEBITDA="-12.06"
Beta="1.094"
num_52WeekHigh="63.08"
num_52WeekLow="23.03"
num_50DayMovingAverage="57.93"
num_200DayMovingAverage="41.84"
SharesOutstanding="45825300"
DividendDate="None"
ExDividendDate="None"
symbol="MORF"
open="54.20"
high="55.28"
low="53.76"
price="54.00"
volume="401834.00"
latest_trading_day="2023-08-11"
previous_close="54.17"
change="-0.17"
change_percent="-0.3138%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="7"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="93"
Volume_recent_avg="535905"
Change_recent_avg="-0.02"
Delta_recent_avg="2.49"
Variance_recent_avg="1.25"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="93"
Aroon_momentum_negative="7"
image_negative_thumbnail_id_1="516"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0089.jpeg"
image_negative_thumbnail_id_2="163"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0013.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="1013"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_positive_thumbnail_id_2="700"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
